| Authors: |
Hamy AS; Department of Medical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France.; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France., Chabassier A; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France., Sebbag C; Department of Medical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France.; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France., Rousset-Jablonski C; Centre Léon Bérard, Lyon, France.; RESearch on HealthcAre PErformance (RESHAPE), University Claude Bernard Lyon 1, Lyon, France., Berkach C; Unité de Génétique Clinique, Hôpital Saint-Louis, APHP, France., Ray-Coquard I; Centre Léon Bérard, Lyon, France.; RESearch on HealthcAre PErformance (RESHAPE), University Claude Bernard Lyon 1, Lyon, France., Sablone L; Seintinelles Research Network, 40 Rue Rémy Dumoncel, Paris, 75014, France., Darrigues L; Department of Surgical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France., Dumas E; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France., Bobrie A; Department of Medical Oncology, Institut du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France., Jacot W; Department of Medical Oncology, Institut du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France., Espié M; Sénopole, Hôpital Saint-Louis, AP-HP, Paris, France.; Université Paris Cité, Paris, France., Giacchetti S; Sénopole, Hôpital Saint-Louis, AP-HP, Paris, France.; Université Paris Cité, Paris, France., Jochum F; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France.; Department of Gynecology, Strasbourg University Hospital, Strasbourg, France., Toussaint A; Department of Medical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France.; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France., Plu-Bureau G; Department of Gynecology, Hôpital Cochin, Paris, France.; Université Paris Cité, Paris, France., Maitrot-Mantelet L; Department of Gynecology, Hôpital Cochin, Paris, France.; Université Paris Cité, Paris, France., Gompel A; Department of Gynecology, Hôpital Cochin, Paris, France.; Université Paris Cité, Paris, France., Gougis P; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France.; Sorbonne Université, INSERM, UNICO-GRECO Cardio-oncology Program, Department of Pharmacology, GRC27, CIC-1901, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France., Bas R; Department of Medical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France., Decanter C; ART Department, Centre Hospitalier Régional Lille, Lille, France., Asselain B; Department of Biostatistics, Unicancer, Paris, France., Coutant C; Clinical Research Department, Centre Georges-François Leclerc (Unicancer), Dijon, France., Sohn L; Seintinelles Research Network, 40 Rue Rémy Dumoncel, Paris, 75014, France., Jacob G; Seintinelles Research Network, 40 Rue Rémy Dumoncel, Paris, 75014, France., Saule C; Department of Medical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France., Frank S; Department of Medical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France., Abécassis J; Project-team Soda, Inria Saclay, Palaiseau, France.; Institut Polytechnique de Paris, Palaiseau, France., Coussy F; Department of Medical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France.; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France., Reyal F; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France.; Department of Surgical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France. |
